Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 51 Records) |
| Query Trace: Recurrence and BCR[original query] |
|---|
| Tumor infiltrating M2 macrophages could predict biochemical recurrence of localized prostate cancer after radical prostatectomy. Experimental cell research 2019 Aug 111588. Zhang Qijie, Xia Jiadong, Wang Yi, Zhang Jiayi, Ji Chengjian, Cong Rong, Wang Yamin, Song Ningho |
| SETD2, GIGYF2, FGFR3, BCR, KMT2C, and TSC2 as candidate genes for differentiating multilocular cystic renal neoplasm of low malignant potential from clear cell renal cell carcinoma with cystic change. Investigative and clinical urology 2019 May 60 (3): 148-155. Kim Sung Han, Park Weon Seo, Chung Jins |
| Prognostic Value of CD1B in Localised Prostate Cancer. International journal of environmental research and public health 2019 12 16 (23): . Lee Cheng-Hsueh, Chen Lih-Chyang, Yu Chia-Cheng, Lin Wen-Hsin, Lin Victor C, Huang Chao-Yuan, Lu Te-Ling, Huang Shu-Pin, Bao Bo-Yi |
| Immune checkpoint-related serum proteins and genetic variants predict outcomes of localized prostate cancer, a cohort study. Cancer immunology, immunotherapy : CII 2020 Sep . Wang Qinchuan, Ye Yuanqing, Yu Hao, Lin Shu-Hong, Tu Huakang, Liang Dong, Chang David W, Huang Maosheng, Wu Xife |
| A 10-gene signature as a predictor of biochemical recurrence after radical prostatectomy in patients with prostate cancer and a Gleason score ?7. Oncology letters 2020 8 20 (3): 2906-2918. Wu Xiangkun, Lv Daojun, Lei Ming, Cai Chao, Zhao Zhijian, Eftekhar Md, Gu Di, Liu Yong |
| Exploration of gene expression profiles and immune microenvironment between high and low tumor mutation burden groups in prostate cancer. International immunopharmacology 2020 6 86 106709. Luo Cheng, Chen Junxing, Chen Ling |
| Genetic Analysis Reveals a Significant Contribution of CES1 to Prostate Cancer Progression in Taiwanese Men. Cancers 2020 May 12 (5): . Ke Chien-Chih, Chen Lih-Chyang, Yu Chia-Cheng, Cheng Wei-Chung, Huang Chao-Yuan, Lin Victor C, Lu Te-Ling, Huang Shu-Pin, Bao Bo-Yi |
| Genetic variants in epithelial-mesenchymal transition genes as predictors of clinical outcomes in localized prostate cancer. Carcinogenesis 2020 Mar . Deng Yang, Xie Kunlin, Logothetis Christopher J, Thompson Timothy C, Kim Jeri, Huang Maosheng, Chang David W, Gu Jian, Wu Xifeng, Ye Yuanqi |
| DNA repair gene polymorphisms, tumor control, and treatment toxicity in prostate cancer patients treated with permanent implant prostate brachytherapy. The Prostate 2020 Mar . Carignan Damien, Lessard Trystan, Villeneuve Lyne, Desjardins Sylvie, Magnan Sindy, Després Philippe, Martin André-Guy, Foster William, Guillemette Chantal, Lévesque Éric, Vigneault Er |
| Genetic association analysis identifies a role for ANO5 in prostate cancer progression. Cancer medicine 2020 Feb . Yu Chia-Cheng, Chen Lih-Chyang, Huang Chao-Yuan, Lin Victor C, Lu Te-Ling, Lee Cheng-Hsueh, Huang Shu-Pin, Bao Bo-Yi |
| Genetic Association Analysis of Cell Cycle Regulators Reveals YWHAZ Has Prognostic Significance in Prostate Cancer. Cancer genomics & proteomics 0 17 (2): 209-216. Yu Chia-Cheng, Chen Lih-Chyang, Lin Wen-Hsin, Lin Victor C, Huang Chao-Yuan, Lu Te-Ling, Lee Cheng-Hsueh, Huang Shu-Pin, Bao Bo-Yi |
| Leukocyte telomere length is associated with aggressive prostate cancer in localized prostate cancer patients. EBioMedicine 2020 Jan 52 102616. Xu Junfeng, Chang Wen-Shin, Tsai Chia-Wen, Bau Da-Tian, Xu Yifan, Davis John W, Thompson Timothy C, Logothetis Christopher J, Gu Ji |
| An Immune-Related lncRNA Signature to Predict the Biochemical Recurrence and Immune Landscape in Prostate Cancer. International journal of general medicine 2021 12 14 9031-9049. Zhang Guian, Luo Yo |
| Utilization of hypoxia-derived gene signatures to predict clinical outcomes and immune checkpoint blockade therapy responses in prostate cancer. Frontiers in genetics 2022 8 13 922074. Chen Minhua, Chen Zhang, Lin Zongbin, Ding Xiang, Liang Tian |
| Orelabrutinib Combined With Lenalidomide and Immunochemotherapy for Relapsed/Refractory Primary Central Nervous System Lymphoma: A Retrospective Analysis of Case Series. Frontiers in oncology 2022 7 12 901797. Yang Chuanwei, Cui Yong, Ren Xiaohui, Li Ming, Yu Kefu, Shen Shaoping, Jiang Haihui, Li Mingxiao, Zhang Xiaokang, Zhao Xuzhe, Zhu Qinghui, Lin So |
| Mutator-Derived lncRNA Landscape: A Novel Insight Into the Genomic Instability of Prostate Cancer. Frontiers in oncology 2022 7 12 876531. Tang Liansha, Li Wanjiang, Xu Hang, Zheng Xiaonan, Qiu Shi, He Wenbo, Wei Qiang, Ai Jianzhong, Yang Lu, Liu Jiy |
| Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group Study. European urology 2022 6 82 (2): 201-211. Burns Daniel, Anokian Ezequiel, Saunders Edward J, Bristow Robert G, Fraser Michael, Reimand Jüri, Schlomm Thorsten, Sauter Guido, Brors Benedikt, Korbel Jan, Weischenfeldt Joachim, Waszak Sebastian M, Corcoran Niall M, Jung Chol-Hee, Pope Bernard J, Hovens Chris M, Cancel-Tassin Géraldine, Cussenot Olivier, Loda Massimo, Sander Chris, Hayes Vanessa M, Dalsgaard Sorensen Karina, Lu Yong-Jie, Hamdy Freddie C, Foster Christopher S, Gnanapragasam Vincent, Butler Adam, Lynch Andy G, Massie Charlie E, , Woodcock Dan J, Cooper Colin S, Wedge David C, Brewer Daniel S, Kote-Jarai Zsofia, Eeles Rosalind |
| Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contribution. The Prostate 2022 Jun . Casadó-Llombart Sergi, Ajami Tarek, Consuegra-Fernández Marta, Carreras Esther, Aranda Fernando, Armiger Noelia, Alcaraz Antonio, Mengual Lourdes, Lozano Francis |
| A transcriptomic signature for prostate cancer relapse prediction identified from the differentially expressed genes between TP53 mutant and wild-type tumors. Scientific reports 2022 6 12 (1): 10561. Zhang Wensheng, Zhang K |
| Genetic variant located on chromosome 17p12 contributes to prostate cancer onset and biochemical recurrence. Scientific reports 2022 3 12 (1): 4546. Pavel Anca Gabriela, Stambouli Danae, Gener Ismail, Preda Adrian, Anton Gabriela, Baston Catal |
| Risk and predictors of adverse pathology after radical prostatectomy in patients diagnosed with IUSP 1-2 prostate cancer at MRI-targeted biopsy: a multicenter analysis. World journal of urology 2022 12 . Kesch Claudia, Pantea Vlad, Soeterik Timo, Marquis Alessandro, la Bombarda Giulia, Morlacco Allesandro, Barletta Francesco, Radtke Jan Philipp, Darr Christopher, Preisser Felix, Zattoni Fabio, Marra Giancarlo, van den Bergh Roderik C N, Hadaschik Boris, Gandaglia Giorgio, |
| Determination of ERG(+), EZH2, NKX3.1, and SPINK-1 subtypes to evaluate their association with clonal origin and disease progression in multifocal prostate cancer. Cancer reports (Hoboken, N.J.) 2022 10 e1728. Segura-Moreno Yenifer Yamile, Sanabria-Salas María Carolina, Mesa-López De Mesa Jorge Andrés, Varela-Ramirez Rodolfo, Acosta-Vega Natalia Lizeth, Serrano Martha Luc |
| The established chemokine-related prognostic gene signature in prostate cancer: Implications for anti-androgen and immunotherapies. Frontiers in immunology 2022 10 13 1009634. Chen Lei, Zheng Yi, Jiang Changqin, Yang Cheng, Zhang Li, Liang Chaozh |
| Evidence on Statins, Omega-3, and Prostate Cancer: A Narrative Review. The world journal of men's health 2022 1 40 (3): 412-424. Kim Hwanik, Kim Jung Kw |
| WWOX Polymorphisms as Predictors of the Biochemical Recurrence of Localized Prostate Cancer after Radical Prostatectomy. International journal of medical sciences 2023 6 20 (7): 969-975. Chia-Yen Lin, Chun-Li Wang, Shian-Shiang Wang, Cheng-Kuang Yang, Jian-Ri Li, Chuan-Shu Chen, Sheng-Chun Hung, Kun-Yuan Chiu, Chen-Li Cheng, Yen-Chuan Ou, Shun-Fa Ya |
| Identification and verification of an ALYREF-involved 5-methylcytosine based signature for stratification of prostate cancer patients and prediction of clinical outcome and response to therapies. Discover. Oncology 2023 5 14 (1): 62. Xiao Tan, Zhouda Cai, Guo Chen, Chao Cai, Jiahong Chen, Yingke Liang, Yangjia Zhuo, Jianming Liu, Liangliang Huang, Bin Ouyang, Yanni Wei, Zhenyu Jia, Junhong Deng, Weide Zhong, Jianming |
| Association of TP53 Single Nucleotide Polymorphisms with Prostate Cancer in a Racially Diverse Cohort of Men. Biomedicines 2023 5 11 (5): . Allison Duncan, Darryl Nousome, Randy Ricks, Huai-Ching Kuo, Lakshmi Ravindranath, Albert Dobi, Jennifer Cullen, Shiv Srivastava, Gregory T Chesnut, Gyorgy Petrovics, Indu Koha |
| Construction and validation of a fatty acid metabolism-related gene signature for predicting prognosis and therapeutic response in patients with prostate cancer. PeerJ 2023 2 11 e14854. Zhao Hongjun, Wu Tong, Luo Zehao, Huang Qinyao, Zhu Sihua, Li Chunling, Zhang Zubing, Zhang Jiahao, Zeng Jianwen, Zhang Yuyi |
| The Prognostic Significance of Selected HLA Alleles on Prostate Cancer Outcome. International journal of molecular sciences 2023 10 24 (19): . Savvas Stokidis, Constantin N Baxevanis, Sotirios P Fort |
| Prognostic significance of steroid response in pediatric acute lymphoblastic leukemia: The CCCG-ALL-2015 study. Frontiers in oncology 2023 1 12 1062065. Chu Jinhua, Cai Huaju, Cai Jiaoyang, Bian Xinni, Cheng Yumei, Guan Xianmin, Chen Xiaoqian, Jiang Hua, Zhai Xiaowen, Fang Yongjun, Zhang Lei, Tian Xin, Zhou Fen, Wang Yaqin, Wang Lingzhen, Li Hong, Kwan Alex Leung Wing, Yang Minghua, Yang Hanfang, Zhan Aijun, Wang Ningling, Hu Shaoy |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 01, 2023
- Content source: